‌

US Patent 9669013 Bicyclic aza compounds as muscarinic M1 receptor agonists

Patent 9669013 was granted and assigned to Heptares Therapeutics on June, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Heptares Therapeutics

Current Assignee

Heptares Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 6, 2017

Patent Application Number

14996829

Date Filed

January 15, 2016

Patent Citations Received

US Patent 12024499 Muscarinic agonists

0

US Patent 11773090 Pharmaceutical compounds

US Patent 11834407 Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

0

US Patent 11945801 Bicyclic aza compounds as muscarinic M

0

Patent Primary Examiner

Niloofar Rahmani

Patent abstract

This invention relates to compounds (Formula (1)) that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where R1-R5, X1, X2 and p are as defined herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9669013 Bicyclic aza compounds as muscarinic M1 receptor agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.